Amitriptyline (25mg) + Methylcobalamin/Mecobalamin (1500mcg)
10 tablets in 1 strip
Cash on delivery available
Amnuring 25 Tablet SR is a prescription medication commonly used to treat certain neurological disorders, such as neuropathic pain and epilepsy. It contains the active ingredient pregabalin, which helps to reduce nerve pain and control seizures. This sustained-release (SR) formulation ensures a steady release of the medication over time for effective symptom management.
Amnuring 25 Tablet SR is primarily prescribed to address neurological disorders such as neuropathic pain, seizures, and anxiety disorders. It contains pregabalin as its active ingredient, which works by modulating the release of certain neurotransmitters in the brain, thereby exerting its therapeutic effects.
The medication is often employed in the management of diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and as an adjunct therapy for partial-onset seizures.
The benefits of Amnuring 25 Tablet SR are multifaceted. By targeting the underlying mechanisms of neuropathic pain and seizures, it helps alleviate symptoms and improves overall quality of life for individuals suffering from these conditions.
Its anxiolytic properties make it a valuable tool in managing anxiety disorders, providing relief from excessive worry, tension, and nervousness.
Moreover, Amnuring 25 Tablet SR is known for its efficacy in diabetic neuropathy, offering relief from the debilitating pain associated with this condition and enhancing sensory functions.
While Amnuring 25 Tablet SR offers numerous therapeutic benefits, it may also be associated with certain side effects. Common side effects include dizziness, drowsiness, dry mouth, blurred vision, weight gain, and edema. These side effects are usually mild to moderate in nature and tend to resolve with continued use or dose adjustments.
In some cases, individuals may experience more severe side effects such as allergic reactions, difficulty breathing, swelling of the face, lips, tongue, or throat, and mood changes. It’s important to promptly report any unusual symptoms to a healthcare provider for proper evaluation and management.
Amnuring 25 Tablet SR should be taken as directed by a healthcare professional. The dosage may vary depending on the specific condition being treated, individual response to the medication, and other factors such as age and overall health.
The tablets are usually taken orally, with or without food, as prescribed. It is important to swallow the tablet whole and not crush, chew, or break it, as this may alter its efficacy or result in an uneven release of the medication.
It’s advisable to adhere to the prescribed dosage regimen and not exceed the recommended dose, as this can increase the risk of adverse effects.
The mechanism of action of Amnuring 25 Tablet SR revolves around its active ingredient, pregabalin. Pregabalin exerts its therapeutic effects by binding to calcium channels in the central nervous system, thereby reducing the release of neurotransmitters such as glutamate, noradrenaline, and substance P.
By modulating the release of these neurotransmitters, pregabalin helps dampen excessive neuronal activity, which is often implicated in neuropathic pain, seizures, and anxiety disorders.
Additionally, pregabalin has been shown to increase the levels of gamma-aminobutyric acid (GABA), a neurotransmitter with inhibitory properties, further contributing to its anxiolytic and anticonvulsant effects.
In summary, Amnuring 25 Tablet SR holds promise as a versatile medication for the management of neurological disorders, offering relief from symptoms and improving overall well-being. However, it is essential to use this medication under the guidance of a healthcare professional and to be vigilant for any potential side effects. With proper usage and monitoring, Amnuring 25 Tablet SR can be a valuable ally in the journey towards better health and wellness.
Cash on delivery available
Available on
+91-9718208060
help@chemistsworld.com
Download App
Track Order
Help Center
Signup 
UPLOAD PRESCRIPTION 
